AllianceBernstein’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $263M | Buy |
4,872,680
+2,217,159
| +83% | +$129M | 0.09% | 178 |
|
|
2025
Q4 | $143M | Sell |
2,655,521
-24,746
| -0.9% | -$1.19M | 0.05% | 291 |
|
|
2025
Q3 | $121M | Sell |
2,680,267
-332,366
| -11% | -$15.5M | 0.04% | 337 |
|
|
2025
Q2 | $139M | Sell |
3,012,633
-295,921
| -9% | -$14.5M | 0.05% | 281 |
|
|
2025
Q1 | $202M | Sell |
3,308,554
-215,852
| -6% | -$12.6M | 0.07% | 207 |
|
|
2024
Q4 | $199M | Sell |
3,524,406
-381,744
| -10% | -$21.3M | 0.07% | 220 |
|
|
2024
Q3 | $202M | Buy |
3,906,150
+160,895
| +4% | +$7.55M | 0.07% | 216 |
|
|
2024
Q2 | $156M | Sell |
3,745,255
-597,124
| -14% | -$26.7M | 0.05% | 258 |
|
|
2024
Q1 | $235M | Buy |
4,342,379
+339,501
| +8% | +$17.3M | 0.08% | 192 |
|
|
2023
Q4 | $205M | Sell |
4,002,878
-571,400
| -12% | -$30M | 0.08% | 200 |
|
|
2023
Q3 | $265M | Sell |
4,574,278
-143,623
| -3% | -$8.8M | 0.11% | 162 |
|
|
2023
Q2 | $302M | Buy |
4,717,901
+389,729
| +9% | +$26.1M | 0.12% | 155 |
|
|
2023
Q1 | $300M | Buy |
4,328,172
+1,323,195
| +44% | +$93.3M | 0.13% | 150 |
|
|
2022
Q4 | $216M | Buy |
3,004,977
+291,333
| +11% | +$22M | 0.1% | 195 |
|
|
2022
Q3 | $193M | Buy |
2,713,644
+46,516
| +2% | +$3.37M | 0.09% | 192 |
|
|
2022
Q2 | $205M | Sell |
2,667,128
-13,286
| -0.5% | -$1.01M | 0.09% | 194 |
|
|
2022
Q1 | $196M | Sell |
2,680,414
-100,505
| -4% | -$6.75M | 0.08% | 242 |
|
|
2021
Q4 | $173M | Sell |
2,780,919
-69,252
| -2% | -$4.06M | 0.06% | 287 |
|
|
2021
Q3 | $169M | Sell |
2,850,171
-371,975
| -12% | -$24.5M | 0.07% | 271 |
|
|
2021
Q2 | $215M | Sell |
3,222,146
-1,611,524
| -33% | -$105M | 0.09% | 223 |
|
|
2021
Q1 | $305M | Buy |
4,833,670
+700,700
| +17% | +$43.6M | 0.13% | 143 |
|
|
2020
Q4 | $256M | Sell |
4,132,970
-742,362
| -15% | -$45.6M | 0.12% | 151 |
|
|
2020
Q3 | $294M | Sell |
4,875,332
-734,402
| -13% | -$44.2M | 0.16% | 112 |
|
|
2020
Q2 | $330M | Buy |
5,609,734
+34,795
| +0.6% | +$2.08M | 0.19% | 97 |
|
|
2020
Q1 | $311M | Sell |
5,574,939
-116,884
| -2% | -$7.14M | 0.22% | 92 |
|
|
2019
Q4 | $365M | Buy |
5,691,823
+1,052,064
| +23% | +$60.3M | 0.21% | 101 |
|
|
2019
Q3 | $235M | Sell |
4,639,759
-165,740
| -3% | -$7.79M | 0.15% | 134 |
|
|
2019
Q2 | $218M | Buy |
4,805,499
+316,326
| +7% | +$14.7M | 0.14% | 144 |
|
|
2019
Q1 | $214M | Buy |
4,489,173
+694,362
| +18% | +$34.6M | 0.14% | 144 |
|
|
2018
Q4 | $197M | Sell |
3,794,811
-91,784
| -2% | -$4.93M | 0.15% | 139 |
|
|
2018
Q3 | $241M | Buy |
3,886,595
+56,474
| +1% | +$3.35M | 0.16% | 134 |
|
|
2018
Q2 | $212M | Sell |
3,830,121
-626,155
| -14% | -$33.8M | 0.15% | 145 |
|
|
2018
Q1 | $282M | Buy |
4,456,276
+1,593,034
| +56% | +$102M | 0.2% | 107 |
|
|
2017
Q4 | $175M | Sell |
2,863,242
-241
| -0% | -$15.1K | 0.13% | 168 |
|
|
2017
Q3 | $183M | Buy |
2,863,483
+170,660
| +6% | +$9.96M | 0.14% | 147 |
|
|
2017
Q2 | $150M | Sell |
2,692,823
-39,449
| -1% | -$2.15M | 0.12% | 175 |
|
|
2017
Q1 | $149M | Sell |
2,732,272
-440,401
| -14% | -$24.2M | 0.12% | 170 |
|
|
2016
Q4 | $185M | Sell |
3,172,673
-10,104
| -0.3% | -$552K | 0.15% | 136 |
|
|
2016
Q3 | $172M | Sell |
3,182,777
-37,459
| -1% | -$2.41M | 0.14% | 145 |
|
|
2016
Q2 | $237M | Buy |
3,220,236
+64,863
| +2% | +$4.58M | 0.2% | 119 |
|
|
2016
Q1 | $202M | Sell |
3,155,373
-5,867
| -0.2% | -$370K | 0.17% | 134 |
|
|
2015
Q4 | $217M | Sell |
3,161,240
-48,074
| -1% | -$3.18M | 0.19% | 126 |
|
|
2015
Q3 | $190M | Sell |
3,209,314
-192,062
| -6% | -$12.2M | 0.16% | 142 |
|
|
2015
Q2 | $226M | Sell |
3,401,376
-1,408,538
| -29% | -$92.8M | 0.19% | 121 |
|
|
2015
Q1 | $310M | Sell |
4,809,914
-93,933
| -2% | -$5.88M | 0.25% | 93 |
|
|
2014
Q4 | $289M | Sell |
4,903,847
-151,628
| -3% | -$8.55M | 0.24% | 98 |
|
|
2014
Q3 | $259M | Sell |
5,055,475
-30,488
| -0.6% | -$1.52M | 0.22% | 109 |
|
|
2014
Q2 | $247M | Sell |
5,085,963
-310,965
| -6% | -$15.3M | 0.21% | 114 |
|
|
2014
Q1 | $280M | Buy |
5,396,928
+794,519
| +17% | +$42.3M | 0.24% | 102 |
|
|
2013
Q4 | $245M | Sell |
4,602,409
-801,253
| -15% | -$40.8M | 0.22% | 108 |
|
|
2013
Q3 | $250M | Sell |
5,403,662
-513,801
| -9% | -$22.6M | 0.25% | 94 |
|
|
2013
Q2 | $264M | Buy |
+5,917,463
| New | +$257M | 0.28% | 86 |
|
Other funds holding BMY
VCM
VPM
AllianceBernstein's BMY Position: Q1 2026 in Review
AllianceBernstein increased its Bristol-Myers Squibb (BMY) stake by 83% in Q1 2026, buying an estimated $129M and bringing the position to 4,872,680 shares worth $263M. The position accounts for 0.09% of the portfolio, ranked #178.
AllianceBernstein first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $365M in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- AllianceBernstein held 4,872,680 shares of Bristol-Myers Squibb worth $263M as of Q1 2026.
- AllianceBernstein bought 2,217,159 Bristol-Myers Squibb shares in Q1 2026, an estimated $129M.
- Bristol-Myers Squibb made up 0.09% of AllianceBernstein's portfolio in Q1 2026, its #178 holding.
- AllianceBernstein first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Bristol-Myers Squibb position peaked at $365M in Q4 2019.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.